share_log

EXCLUSIVE: Pasithea Therapeutics Acquires Alpha-5 Integrin For Closing Consideration Of 3.26M Shares Of Pasithea Common Stock

Benzinga Real-time News ·  Jun 22, 2022 07:30
EXCLUSIVE: Pasithea Therapeutics Acquires Alpha-5 Integrin For Closing Consideration Of 3.26M Shares Of Pasithea Common Stock
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment